BDRX's logo.
Ticker Symbol: BDRX

Biodexa Pharmaceuticals Plc - ADR

Exchange: NASDAQ Country: United Kingdom Currency: USD Asset Type: ADR CIK:0001643918

Company Profile

midatech is a world leader in the design, synthesis and manufacture of biocompatible gold nanoparticles (gnps) with a core focus on therapeutics for diabetes and cancer. midatech has a strong pipeline of product candidates in clinical and pre-clinical development for the treatment of diabetes and various cancers. in 2012, midatech established midasol therapeutics lp, a strategic joint venture with monosol rx llc to focus on the development and commercialization, via partnering or licensing, of products primarily for the treatment of diabetes. midasol’s lead product, midaform™ insulin pharmfilm, is a unique product for the oral delivery of insulin in diabetic patients and will enter phase ii clinical studies in 2014. these technologies are also being evaluated in the diabetes area by a major us pharmaceutical company. midatech’s unique gnp technology enables the administration and targeted delivery of therapeutic compounds to specific cells and tissues. multiple drug molecules can b

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Oddfellows Hse
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.63
Change: -$0.27 ( -6.92%)
Days Range: $3.48 - $3.94
Beta: -
52wk. High: $130.40
52wk. Low: $1.13
Ytd. Change -14.79%
50 Day Moving Average: $5.23
200 Day Moving Average: $9.21
Shares Outstanding: 236574

Valuation

Market Cap: 85.9M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A